Annual report pursuant to section 13 and 15(d)

Consolidated Balance Sheets

v2.4.0.6
Consolidated Balance Sheets (USD $)
Dec. 31, 2012
Dec. 31, 2011
Current assets:    
Cash $ 2,354,169 $ 129,152
Marketable securities - available for sale securities 12,500   
Prepaid expenses 40,333   
Assets of discontinued operations - current portion 82,145 20,000
Total current assets 2,489,147 149,152
Other assets:    
Intangible assets, net 492,152   
Assets of discontinued operations - long term portion 1,035,570 3,500
Total other assets 1,527,722 3,500
Total Assets 4,016,869 152,652
Current liabilities:    
Accounts payable and accrued expenses 57,158 4,000
Notes payable - related party    152,974
Advances payable    100,000
Liabilities of discontinued operations 30,664   
Total liabilities 87,822 256,974
Stockholders' Equity (deficit):    
Preferred stock, $.0001 par value, 50,000,000 shares authorized: none issued and outstanding      
Common stock, ($.0001 par value; 200,000,000 shares authorized; 45,546,345 and 10,000,000 issued and outstanding at December 31, 2012 and 2011 4,555 1,000
Additional paid-in capital 10,972,122 4,000
Deficits accumulated during the development stage (7,037,134) (109,322)
Total Marathon Patent Group, Inc. equity (deficit) 3,939,543 (104,322)
Non-controlling interest in subsidiary (10,496)   
Total stockholders' equity (deficit) 3,929,047 (104,322)
Total liabilities and stockholders' equity (deficit) $ 4,016,869 $ 152,652